Ever since we began covering them as the first Russian bioprinting company, 3D Bioprinting Solutions, or 3dbio for short, came across as more focused on raising awareness on bioprinting by conducting high profile experiments than on exploring commercial applications for the future of bioprinting.
Visiting the company’s lab in Moscow, and speaking with Co-founder Yusef Khesuani, we learned that it may be exactly the opposite: maybe we are not talking about 3dbio nearly as much as we should.
In fact, that may all be changing now with some more announcements coming up in the next few weeks. One of the main issues limiting 3dbio’s visibility in Western Europe and North America may be related to the fact that they are based in Russia. Due to generalized lack of awareness of Russian matters in the West, the way for 3dbio to get some well-deserved recognition has been to do […]
Drones bring great energy to the design and 3D printing realm, with engineers engaged in developing new technology...